Back to Search
ADRIAN PAVLICK, M.D.
M.D.
Family Medicine Physician
NPI: 1750647376IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
207986(LA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2012
Research & Publications (20)
A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor.
PMID 15075667·Anticancer Drugs·2004
3-trial
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
PMID 19666588·Proc Natl Acad Sci U S A·2009
8-other
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.
PMID 19643020·BMC Cancer·2009
3-trial
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
PMID 19451711·Chemotherapy·2009
3-trial
Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
PMID 19336517·Clin Cancer Res·2009
8-other
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma.
PMID 19318491·Clin Cancer Res·2009
8-other
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
PMID 19221754·Cancer Chemother Pharmacol·2009
3-trial
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.
PMID 19140204·Cancer·2009
3-trial
Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).
PMID 19117354·Cancer·2009
1-meta
Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients.
PMID 19025658·J Transl Med·2008
8-other
Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.
PMID 19010919·Cancer Res·2008
8-other
Changes in the presentation of nodular and superficial spreading melanomas over 35 years.
PMID 18988292·Cancer·2008
8-other
Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.
PMID 18829505·Clin Cancer Res·2008
8-other
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.
PMID 18566444·J Immunol·2008
3-trial
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
PMID 18445819·J Natl Cancer Inst·2008
8-other
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
PMID 18235116·J Clin Oncol·2008
3-trial
Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.
PMID 17625806·Cancer Immun·2007
8-other
Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma.
PMID 17620286·Cancer·2007
8-other
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
PMID 17517626·Proc Natl Acad Sci U S A·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2300 HOSPITAL DR, SUITE 180
BOSSIER CITY, LA 71111 - Phone
- (318) 212-7520
Quick Facts
- NPI
- 1750647376
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile